Multiple system degeneration with glutamate dehydrogenase deficiency: pathology and biochemistry

Chokroverty, S; Nicklas, W; Miller, D C; Goldberg, J; Choe, J; Banner, C; Thomas, J; Duvoisin, R
December 1990
Journal of Neurology, Neurosurgery & Psychiatry;Dec1990, Vol. 53 Issue 12, p1099
Academic Journal
No abstract available.


Related Articles

  • The role of glutamate and its receptors in multiple sclerosis. Stojanovic, Ivana; Kostic, Milos; Ljubisavljevic, Srdjan // Journal of Neural Transmission;Aug2014, Vol. 121 Issue 8, p945 

    Glutamate is an excitatory neurotransmitter of the central nervous system, which has a central role in a complex communication network established between neurons, astrocytes, oligodendrocytes, and microglia. Multiple abnormal triggers such as energy deficiency, oxidative stress, mitochondrial...

  • White-matter astrocytes, axonal energy metabolism, and axonal degeneration in multiple sclerosis. Cambron, Melissa; D'Haeseleer, Miguel; Laureys, Guy; Clinckers, Ralph; Debruyne, Jan; De Keyser, Jacques // Journal of Cerebral Blood Flow & Metabolism;Mar2012, Vol. 32 Issue 3, p413 

    In patients with multiple sclerosis (MS), a diffuse axonal degeneration occurring throughout the white matter of the central nervous system causes progressive neurologic disability. The underlying mechanism is unclear. This review describes a number of pathways by which dysfunctional astrocytes...

  • A further update on the role of excitotoxicity in the pathogenesis of Parkinson's disease. Ambrosi, Giulia; Cerri, Silvia; Blandini, Fabio // Journal of Neural Transmission;Aug2014, Vol. 121 Issue 8, p849 

    Increased levels of extracellular glutamate and hyperactivation of glutamatergic receptors in the basal ganglia trigger a critical cascade of events involving both intracellular pathways and cell-to-cell interactions that affect cell viability and promote neuronal death. The ensemble of these...

  • Piscator. Hallworth, Mike // Annals of Clinical Biochemistry;May2000, Vol. 37 Issue 3, p417 

    The article discusses developments in clinical biochemistry. The steady increase in substance abuse in Great Britain and other countries has been accompanied by a concomitant rise in renal sequelae. There has been a series of advances in the understanding of the membrane physiology of insulin...

  • Paniculite traumática em um cão. Dal-Bó, Ísis dos Santos; Macedo, Aline Schafrum; Gottlieb, Juliana; Correa, Thaís Oliveira; Blatt Duda, Naila Cristina; Idalencio, Renan; da Silva, Luciana Machado; Alievi, Marcelo Meller // Acta Scientiae Veterinariae;2012, Vol. 40 Issue 4, Special section p1 

    Background: Panniculitis can be associated with a group of multifactorial diseases that develop intense inflammatory response of the subcutaneous fat tissue. The damaged fat cells suffer hydrolysis and saponification. The etiology remains unknown, although it has been associated with infectious...

  • Glutamate receptors, neurotoxicity and neurodegeneration. Lau, Anthony; Tymianski, Michael // Pflugers Archiv European Journal of Physiology;Jul2010, Vol. 460 Issue 2, p525 

    Glutamate excitotoxicity is a hypothesis that states excessive glutamate causes neuronal dysfunction and degeneration. As glutamate is a major excitatory neurotransmitter in the central nervous system (CNS), the implications of glutamate excitotoxicity are many and far-reaching. Acute CNS...

  • Glutamate transport and metabolism in dopaminergic neurons of substantia nigra: implications for the pathogenesis of Parkinson’s disease. Plaitakis, A.; Shashidharan, P. // Journal of Neurology;Apr2000 Supplement 2, Vol. 247, pII25 

    Parkinson’s disease (PD) is associated with degeneration of the pigmented dopaminergic neurons located in the ventral mesencephalon. Although the mechanisms by which these neurons degenerate in PD are poorly understood, indirect evidence suggests involvement of glutamatergic mechanisms in...

  • Molecular and Cellular Mechanism of Glutamate Receptors in Relation to Amyotrophic Lateral Sclerosis. Iwasaki, Yasuo; Ikeda, Ken; Kinoshita, Masao // Current Drug Targets - CNS & Neurological Disorders;Oct2002, Vol. 1 Issue 5, p511 

    Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disorder of the central nervous system (CNS) with an unknown etiology. This disorder is characterized clinically by muscular weakness and wasting, and pathologically by selective degeneration of the corticospinal tracts and motor...

  • Role of brain glutamic acid metabolism changes in neurodegenerative pathologies. Kanunnikova, Nina P. // Journal of Biology & Earth Sciences;Jan-Jun2012, Vol. 2 Issue 1, pM1 

    Glutamic acid is an essential participant of brain metabolism. I t is known that the glutamate is a neurotransmitter in a numerous part of the brain synapses and acts through various ionotropic or metabotropic receptors. Multiple alterations of the brain glutamate system are observed in both...

  • Unaltered cytochrome oxidase, glutamate dehydrogenase and glutaminase activities in platelets from patients with Sporadic Amyotrophic Lateral Sclerosis : A study of potential pathogenetic mechanisms in neurodegenerative diseases. Gluck, M. R.; Thomas, R. G.; Sivak, M. A. // Journal of Neural Transmission;Dec2000, Vol. 107 Issue 12, p1437 

    Summary. Sporadic Amyotrophic Lateral Sclerosis (SALS) is a fatal neurologic disease characterized by degeneration of motor neurons in the spinal cord, brainstem and cortex. While familial cases of ALS exist, the sporadic form accounts for the majority of adult-onset cases. It has been...


Read the Article


Sign out of this library

Other Topics